- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Grage Glioma in Switzerland
Total 165 results
-
Jasper GerritsenMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Glioblastoma Multiforme | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Glioblastoma Multiforme of BrainUnited States, Belgium, Switzerland, Germany, Netherlands
-
Novartis PharmaceuticalsRecruitingGlioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal AdenocarcinomaNetherlands, Spain, Israel, United States, Switzerland
-
CarTheraRecruitingGlioblastoma | GBM | Recurrent GlioblastomaFrance, United States, Spain, Belgium, Switzerland, Germany, Italy, Netherlands
-
Insel Gruppe AG, University Hospital BernEuropean Organisation for Research and Treatment of Cancer - EORTCRecruitingGlioblastomaGermany, Switzerland, Austria, Greece, Italy, Portugal, Romania
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland
-
Amsterdam UMCRecruitingBarrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaNetherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownBarrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaFrance, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
-
AstraZenecaTerminatedElevated High-sensitivity C-Reactive Protein (hsCRP)United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsFrance, Spain, Belgium, Netherlands, Switzerland, Italy
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsFrance, Switzerland, Italy, Belgium, Austria, United Kingdom, Netherlands
-
Jasper GerritsenMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Glioblastoma Multiforme | Recurrent Glioblastoma | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Glioblastoma Multiforme of Brain | Astrocytoma of Brain | Astrocytoma, MalignantUnited States, Germany, Netherlands, Switzerland, Belgium
-
European Organisation for Research and Treatment...RecruitingMedulloblastomaFrance, Netherlands, Spain, Australia, Germany, Switzerland, Austria, Italy
-
Alnylam PharmaceuticalsRecruitingHypertension | High Cardiovascular RiskUnited States, Canada, Switzerland, United Kingdom
-
Societe Internationale d'Oncologie PediatriqueCompletedPrimary Central Nervous System NeoplasmsFrance, United Kingdom, Italy, Germany, Switzerland, Belgium, Denmark, Norway, Austria, Croatia, Poland, Portugal
-
European Organisation for Research and Treatment...PfizerCompletedBrain and Central Nervous System TumorsUnited Kingdom, Switzerland, Belgium, Italy, Germany, France, Netherlands, Spain
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Centre Leon BerardMinistry of Health, FranceTerminatedHistologically Confirmed Medulloblastoma | Activation of the Sonic Hedgehog (SHH) PathwayFrance, Italy, Switzerland, United Kingdom
-
NovoCure Ltd.CompletedRecurrent Glioblastoma MultiformeUnited States, Israel, Switzerland, Austria, Czech Republic, France, Germany
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Novartis PharmaceuticalsCompletedMedulloblastomaFrance, Spain, Germany, Italy, Netherlands, United Kingdom, Canada, Australia, Sweden, United States, Brazil, Switzerland, Russian Federation
-
Centre Leon BerardRecruitingChildhood EpendymomaItaly, Denmark, France, Czechia, Sweden, Germany, Slovenia, United Kingdom, Austria, Belgium, Ireland, Netherlands, Norway, Spain, Switzerland
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsFrance, Switzerland, Italy, Israel, Netherlands, Portugal, Austria, Greece
-
Erasmus Medical CenterMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Brain Neoplasms | Recurrent Glioblastoma | Recurrent Adult Brain Tumor | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme of Brain | Brain Neoplasms, Adult, Malignant | Astrocytoma, Malignant | Brain Neoplasms, AdultUnited States, Germany, Switzerland, Belgium, Netherlands
-
La Jolla Pharmaceutical CompanyCompletedSepsis | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output ShockUnited States, Canada, Belgium, Australia, United Kingdom, Finland, New Zealand, France, Switzerland, Germany
-
Hoffmann-La RocheCompletedGlioblastomaUnited States, United Kingdom, France, Italy, Spain, Germany, Canada, Switzerland
-
Global Coalition for Adaptive ResearchBayer; Kazia Therapeutics Limited; Biohaven Pharmaceuticals, Inc.; Kintara Therapeutics... and other collaboratorsRecruitingGlioblastomaUnited States, France, Germany, Canada, Australia, Switzerland
-
European Organisation for Research and Treatment...Celgene; Canadian Cancer Trials GroupCompletedNewly Diagnosed GlioblastomaUnited States, Belgium, Canada, Spain, Netherlands, France, Switzerland, Germany, Norway, Denmark, Austria, United Kingdom
-
Novartis PharmaceuticalsCompletedGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma, Childhood and other conditionsUnited States, Italy, Japan, Germany, Spain, France, Canada, Australia, Brazil, Israel, Russian Federation, Argentina, United Kingdom, Finland, Belgium, Denmark, Czechia, Sweden, Switzerland, Netherlands
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Ablynx, a Sanofi companyCompletedUnstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia
-
NovoCure Ltd.CompletedGlioblastoma MultiformeUnited States, Spain, France, Canada, Korea, Republic of, Austria, Israel, Czech Republic, Germany, Italy, Sweden, Switzerland
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedCentral Nervous System TumorsNetherlands, France, Switzerland, United Kingdom, Belgium, Germany, Austria, Italy
-
BeiGene USA, Inc.CompletedBrain and Central Nervous System TumorsUnited States, Netherlands, Switzerland
-
Hoffmann-La RocheCompletedGlioblastomaUnited States, United Kingdom, Belgium, Denmark, Korea, Republic of, Poland, Spain, Canada, Sweden, Russian Federation, Australia, Greece, Portugal, France, Netherlands, New Zealand, Switzerland, Germany, Hong Kong, Hungary, Israel and more
-
CNS Pharmaceuticals, Inc.Worldwide Clinical TrialsActive, not recruitingGlioblastoma Multiforme, AdultUnited States, Spain, France, Switzerland, Italy
-
Bristol-Myers SquibbActive, not recruitingRecurrent GlioblastomaPoland, United Kingdom, United States, Spain, Australia, Germany, Italy, Denmark, Belgium, France, Netherlands, Switzerland
-
ChimerixRecruitingGlioma | H3 K27MUnited States, Australia, Canada, Spain, Switzerland, Israel, Germany, Italy, United Kingdom, Korea, Republic of, Netherlands, Denmark, Austria
-
NovoCure GmbHActive, not recruitingGlioblastoma MultiformeUnited States, United Kingdom, Israel, Germany, Japan, Canada, France, Switzerland, Belgium, Czechia, Austria
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
European Organisation for Research and Treatment...Medical Research CouncilCompletedBrain and Central Nervous System TumorsFrance, Switzerland, Netherlands, United Kingdom, Belgium, Germany, Italy, Sweden, Finland, Portugal, Austria, Hungary
-
AbbVieRadiation Therapy Oncology GroupCompletedGlioblastoma | GliosarcomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Germany, Hong Kong, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian Federation, Singapor... and more
-
Children's Oncology GroupNational Cancer Institute (NCI); Pediatric Oncology GroupCompletedBrain Tumors | Central Nervous System TumorsUnited States, Puerto Rico, Switzerland, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingUntreated Childhood MedulloblastomaUnited States, Canada, Australia, New Zealand, Switzerland, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumors | Central Nervous System TumorsUnited States, Canada, Netherlands, Puerto Rico, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)TerminatedBrain Tumors | Central Nervous System TumorsUnited States, Australia, Canada, Switzerland
-
Universitätsklinikum Hamburg-EppendorfDeutsche KinderkrebsstiftungActive, not recruitingBrain TumorsGermany, Denmark, United Kingdom, Belgium, Poland, Ireland, Austria, Italy, Czechia, France, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland
-
AbbVieEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedGlioblastomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Singapore, Spain, Switzerland, Taiwan, United Kingdom